Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026–2035

Julio Rosenstock; Ronnie Aronson; George Grunberger; Markolf Hanefeld; PierMarco Piatti; Pierre Serusclat; Xi Cheng; Tianyue Zhou; Elisabeth Niemoeller; Elisabeth Souhami; Melanie Davies

doi:10.2337/dc17-er06c

Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026–2035

Diabetes Care ◽

10.2337/dc17-er06c ◽

2017 ◽

Vol 40 (6) ◽

pp. 809.1-809

Author(s):

Julio Rosenstock ◽

Ronnie Aronson ◽

George Grunberger ◽

Markolf Hanefeld ◽

PierMarco Piatti ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Trial ◽

Diabetes Care ◽

Fixed Ratio ◽

Oral Agents

Download Full-text

Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972–1980

Diabetes Care ◽

10.2337/dc17-er06d ◽

2017 ◽

Vol 40 (6) ◽

pp. 809.2-809

Author(s):

Vanita R. Aroda ◽

Julio Rosenstock ◽

Carol Wysham ◽

Jeffrey Unger ◽

Diego Bellido ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Trial ◽

Diabetes Care ◽

Basal Insulin ◽

Fixed Ratio ◽

Efficacy And Safety

Download Full-text

Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial

Diabetes Care ◽

10.2337/dc16-0917 ◽

2016 ◽

Vol 39 (11) ◽

pp. 2026-2035 ◽

Cited By ~ 111

Author(s):

Julio Rosenstock ◽

Ronnie Aronson ◽

George Grunberger ◽

Markolf Hanefeld ◽

PierMarco Piatti ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Trial ◽

Fixed Ratio ◽

Oral Agents

Download Full-text

Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial

Diabetes Care ◽

10.2337/dc16-0046 ◽

2016 ◽

Vol 39 (9) ◽

pp. 1579-1586 ◽

Cited By ~ 51

Author(s):

Julio Rosenstock ◽

Michaela Diamant ◽

Vanita R. Aroda ◽

Louise Silvestre ◽

Elisabeth Souhami ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Trial ◽

Fixed Ratio ◽

Proof Of Concept ◽

Efficacy And Safety ◽

Metformin Monotherapy

Download Full-text

Clinical Impact of Titratable Fixed-Ratio Combination of Insulin Glargine/Lixisenatide vs. Each Component Alone in Type 2 Diabetes Inadequately Controlled on Oral Agents: LixiLan-O Trial (NCT02058147)

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2016.08.126 ◽

2016 ◽

Vol 40 (5) ◽

pp. S44-S45

Author(s):

Ronnie Aronson ◽

Markolf Hanefeld ◽

Piermarco Piatti ◽

Pierre Serusclat ◽

Xi Cheng ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Fixed Ratio ◽

Clinical Impact ◽

Oral Agents

Download Full-text

Effect of a single dose of insulin glargine/lixisenatide fixed ratio combination (iGlarLixi) on postprandial glucodynamic response in Japanese patients with type 2 diabetes mellitus: A phase I randomized trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13757 ◽

2019 ◽

Vol 21 (8) ◽

pp. 2001-2005 ◽

Cited By ~ 4

Author(s):

Megumi Inoue ◽

Martin Lorenz ◽

Hideya Muto ◽

Roland Wesch ◽

Yasuhiro Hashimoto

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Single Dose ◽

Insulin Glargine ◽

Phase I ◽

Randomized Trial ◽

Fixed Ratio ◽

Japanese Patients

Download Full-text

Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial

Diabetes Care ◽

10.2337/dc16-1495 ◽

2016 ◽

Vol 39 (11) ◽

pp. 1972-1980 ◽

Cited By ~ 104

Author(s):

Vanita R. Aroda ◽

Julio Rosenstock ◽

Carol Wysham ◽

Jeffrey Unger ◽

Diego Bellido ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Trial ◽

Basal Insulin ◽

Fixed Ratio ◽

Efficacy And Safety

Download Full-text

Comment on Tang et al. Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial. Diabetes Care 2015;38:1339–1346

Diabetes Care ◽

10.2337/dc15-0887 ◽

2015 ◽

Vol 38 (9) ◽

pp. e148-e149

Author(s):

Peng-Fei Shan ◽

Xiao-li Ji ◽

Liuhong Wang ◽

Ping Li ◽

Yue-Zhong Ren

Keyword(s):

Type 2 Diabetes ◽

Magnetic Resonance ◽

Insulin Glargine ◽

Randomized Trial ◽

Diabetes Care ◽

Liver Fat

Download Full-text

Response to Comment on Tang et al. Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial. Diabetes Care 2015;38:1339–1346

Diabetes Care ◽

10.2337/dc15-1091 ◽

2015 ◽

Vol 38 (9) ◽

pp. e150-e151 ◽

Cited By ~ 1

Author(s):

An Tang ◽

Rémi Rabasa-Lhoret ◽

Hélène Castel ◽

Claire Wartelle-Bladou ◽

Guillaume Gilbert ◽

...

Keyword(s):

Type 2 Diabetes ◽

Magnetic Resonance ◽

Insulin Glargine ◽

Randomized Trial ◽

Diabetes Care ◽

Liver Fat

Download Full-text

Exenatide Versus Insulin Glargine in Patients With Suboptimally Controlled Type 2 Diabetes: A Randomized Trial

Yearbook of Endocrinology ◽

10.1016/s0084-3741(08)70285-3 ◽

2006 ◽

Vol 2006 ◽

pp. 56-61

Author(s):

J.L. Leahy ◽

L. Kennedy

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Trial

Download Full-text

Effectiveness of IGlarLixi, a Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide, in People with Type 2 Diabetes

Diabetes Therapy ◽

10.1007/s13300-021-01128-5 ◽

2021 ◽

Author(s):

János Tibor Kis ◽

Gábor Nagy ◽

Gábor Kovacs

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Fixed Ratio

Download Full-text